Evaluation of NT PRO BNP Guided Therapy on Hospitalization Rate and Mortality in Patients With Chronic HF NYHA II-IY

Completed

• Conditions: Chronic Heart Failure

• Registration Number: NCT00469001
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.

Detailed Description

Group of 100 patients with CHF, NYHA II-IY will be followed for 1 years in outpatient clinic of our hospital for hospitalization, death, 6 min walking protocol, number of decompensation as a primary end point. 50 patients will be treated according usual practice in outpatient clinics and in 50 patients will be additionally used level of NT Pro BNP as additional parameter.If level NT Pro BNP will be goes down will not be changes in treatment regiment. If level of NT Pro BNP will be increased treatment will be intensified.At the end of 1 year follow up we will compare the result of two strategies.

Study Timeline

• Study First Submitted: 2007-05-02
• Study First Submitted QC: 2007-05-02
• Study First Posted: 2007-05-03
• Study Start: 2007-06
• Primary Completion: 2010-01
• Study Completion: 2010-03
• Status Verified: 2010-09
• Last Update Submitted: 2010-09-12
• Last Update Posted: 2010-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• Patient older 18 y.old with CHF NYHA II-IY.

Exclusion Criteria

• All conditions with life expectancy less than 2 years.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel